biotech investing Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
biotech investing Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Alvopetro Announces 2025 Year End Reserves Including a 79% Increase in 1P Reserves, 2P Production Replacement Ratio of 530% and 2026 Capital Plan
